FDA advisory panel recommends use of Merck's COVID-19 pill
The Food and Drug Administration's Antimicrobial Drugs Advisory Committee voted on Tuesday to recommend emergency authorization of molnupiravir, Merck's oral COVID-19 treatment pill.
It was a narrow vote of 13-10, and some panel members said that after they weighed the risks and benefits, they felt there were still too many unanswered questions about the pill's safety and whether it could enable the virus to mutate into variants that can get around current vaccines, CNBC reports.
Dr. Michael Green, a pediatric transplant specialist at the University of Pittsburgh School of Medicine Division of Infectious Diseases, voted in favor of the drug, and said he supported emergency authorization because there aren't many therapies for high-risk individuals with COVID-19. Still, it was "a very difficult decision," Green said, and he recommends that the pill only be used by unvaccinated people at most risk of severe COVID-19.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Molnupiravir is an antiviral drug that is designed to treat adults with mild to moderate COVID-19 symptoms who are at high risk of severe illness. It would be given to patients at home, in the form of an 800 milligram pill taken every 12 hours for five days following the start of symptoms. On Tuesday, Merck presented new data to the FDA showing that the drug was 30 percent effective in preventing hospitalizations and death from COVID-19. The company also said the drug should not be given to children and pregnant women.
Before the public can use the drug on an emergency basis, final authorization has to come from the FDA and the Centers for Disease Control and Prevention; typically, the FDA follows along with the Antimicrobial Drugs Advisory Committee's recommendations.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Long summer days in Iceland's highlands
The Week Recommends While many parts of this volcanic island are barren, there is a 'desolate beauty' to be found in every corner
By The Week UK Published
-
The Democrats: time for wholesale reform?
Talking Point In the 'wreckage' of the election, the party must decide how to rebuild
By The Week UK Published
-
5 deliciously funny cartoons about turkeys
Cartoons Artists take on pardons, executions, and more
By The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published